InvaGen Pharmaceuticals

Fast growing generic pharmaceutical company.

Launch date

2003

Employees

Market cap

Enterprise valuation

CAD682m (Public information from Sep 2015)

Town of Smithtown New York (HQ)

Date	Investors	Amount	Round
Sep 2015	Cipla	$500m Valuation: $500m	Acquisition
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about InvaGen Pharmaceuticals